EyePoint EYPT
NASDAQ EYPT
$0.40 -0.03 (-6.98%)
At close: Oct 23, 2026 · 4:00 PM EDT

EyePoint (EYPT) Gains from Investment Securities (2010 - 2018)

Updated

Analysis

EyePoint (EYPT) Gains from Investment Securities (2010 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 EyePoint 33.99 Mn -879.13 Mn 507,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 18.89 Mn
Sep 30, 2018 -18.89 Mn
Mar 31, 2018 -2.33 Mn
Dec 31, 2011 128,000.00
Sep 30, 2011 42,000.00
Jun 30, 2011 10,000.00
Mar 31, 2011 334,000.00
Dec 31, 2010 458,000.00
Sep 30, 2010 338,000.00
API Access

EyePoint Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=EYPT&period=max&api_key=YOUR_API_KEY